Synta Announces Poster Presentations at the American Association for Cancer Research Annual Meeting
LEXINGTON, Mass.—-Synta Pharmaceuticals Corp. , a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that Synta will present multiple posters at the American Association for Cancer Research 101st Annual Meeting 2010 to be held April 17-21, 2010 in Washington, DC.
Cancer Survivors USA Episode 1 (Stage IV Melanoma)

Comments are closed